MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    The Impact of the Edmond J. Safra Nurse Educator Program at the Parkinson’s Foundation on Nursing Education and Parkinson’s Care

    A. Li Wong (New York, USA)

    Objective: To explore the influence of the Edmond J. Safra Nurse Educator Program on nursing education and its impact on preparing future nurses to care for…
  • 2026 International Congress

    Overactive Bladder in Parkinson’s Disease: A Frequent but Underrecognized Non-Motor Symptom

    AR. Rahma, N. Raisa, DR. Rahmawati, H. - (Malang, Indonesia)

    Objective: To analyze the relationship between overactive bladder (OAB) symptoms and Parkinson's disease (PD) severity with quality of life (QoL) in PD patients Background: Parkinson's…
  • 2026 International Congress

    Digitizing PD Rating Scales Increases Reliability and Accessibility

    Z. Yekutieli, Y. Yahalom, P. Lewitt (Tel-Aviv, Israel)

    Objective: Eliminate intra- and inter-rater variability by using digital means for rating scales and making them accessible for all. Background: Conventional clinician-rated scales like UPDRS…
  • 2026 International Congress

    Parkinson’s Disease and Parkinsonism Family Center Psychoeducational Program for Patients and Caregivers

    M. Serini, C. Aiello, G. Garavaglia, I. Riela, D. Devoto, M. Barichella, M. Macchione, E. Sacilotto, I. Sconfietti, I. Isaias, R. Giove, A. Ranghetti, D. Calandrella, G. Pezzoli (Milano, Italy)

    Objective: To provide structured psychoeducational and informational support, including disease education, coping and self-management strategies, and guidance on healthcare and social services for Parkinson’s disease…
  • 2026 International Congress

    Distinct Non-Motor Symptom Progression Subtypes in Parkinson’s Disease Identified Using a Data-Driven SuStaIn Model

    JY. Liu, AQ. Huang, SY. Liu, Z. Ruan, P. Chan (Beijing, China)

    Objective: To identify progression-oriented non-motor symptom subtypes in PD using a probabilistic Subtype and Stage Inference (SuStaIn) model applied to routinely available clinical assessments. Background:…
  • 2026 International Congress

    Strategies for Harmonising Clinical Data for Multi-Centre, Large Scale Genome-Wide Association Studies

    M. Martín-Bórnez, E. Navarro-Jones, MT. Periñan, L. Jones, H. Iwaki, H. Morris, R. Real (Sevilla, Spain)

    Objective: To establish a data harmonisation framework for classifying cognitive status in Parkinson’s disease (PD) across multiple study and data types to facilitate large-scale genetic…
  • 2026 International Congress

    Dentatothalamic Projections Mediate Tremor Relief Across Deep Brain Stimulation Targets and Tremor Types

    C. Van-Der-Linden, T. Dembek, V. Visser-Vandewalle, A. Horn, M. Barbe, J. Petry-Schmelzer (Cologne, Germany)

    Objective: To investigate the neuroanatomical hotspots for the suppression of rest, postural and intention tremor in Parkinson’s Disease (PD) and Essential Tremor (ET) treated with…
  • 2026 International Congress

    Parkinson’s Disease Early Diagnostic and Prognostic Biomarkers Identified by Large-scale Plasma and Cerebrospinal Fluid Proteomic Profiling

    XY. Li, YL. Tang, J. Wang (Shanghai, China)

    Objective: To identify reliable diagnostic and prognostic protein biomarkers for early-stage Parkinson’s disease (PD) using large-scale proteomic profiling of plasma and cerebrospinal fluid (CSF).To identify…
  • 2026 International Congress

    Sex-Specific Associations of APOE ε4 with Cognitive Decline in Parkinson’s Disease: Insights from the Critical Path Institute GEM-PD Initiative

    R. Botta, J. Locascio, R. Ye, A. Goodheart, D. Stephenson, S. Gomperts (Tucson, USA)

    Objective: We aim to advance precision medicine strategies for Parkinson’s disease (PD) through data-driven research led by the Critical Path for Parkinson’s (CPP) global public-private…
  • 2026 International Congress

    A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson’s disease symptoms

    C. Moreau, F. Marchand, J. Bene, C. Leclercq, V. Foutel, M. Fisichella, D. Devos (Lille, France)

    Objective: To investigate the safety and efficacy of continuous circadian and personalized intracerebroventricular (i.c.v.) administration of anaerobic dopamine (A-dopamine) in Parkinson's disease patients refractory to…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley